John Cumming

Transmed7 LLC is a medical and technology-based organization that focuses on developing innovative, minimally-invasive medical devices for doctors and their patients. The private company is based in Phoenix, AZ. The company's portfolio of next-generation platform devices is expected to be market leaders in oncology, regenerative medicine, and cardiovascular disease. Transmed7's business plan and structure enable these new transformational technologies to move from rapid development through commercial manufacturing and market deployment. The company's transformational forward-coring, zero5 biopsy devices improve patient care with broad applications to breast, soft tissue, endoscopy, laparoscopy, robotics, vascular, bone marrow, and more. The company was founded in 2010 by Eugene H. Vetter, James W. Vetter. Eugene H. Vetter has been the CEO since 2010.

Transmed7 LLC is a medical and technology-based organization that focuses on developing innovative, minimally-invasive medical devices for doctors and their patients. The private company is based in Phoenix, AZ. The company's portfolio of next-generation platform devices is expected to be market leaders in oncology, regenerative medicine, and cardiovascular disease. Transmed7's business plan and structure enable these new transformational technologies to move from rapid development through commercial manufacturing and market deployment. The company's transformational forward-coring, zero5 biopsy devices improve patient care with broad applications to breast, soft tissue, endoscopy, laparoscopy, robotics, vascular, bone marrow, and more. The company was founded in 2010 by Eugene H. Vetter, James W. Vetter. Eugene H. Vetter has been the CEO since 2010.

Transmed7 LLC is a medical and technology-based organization that focuses on developing innovative, minimally-invasive medical devices for doctors and their patients. The private company is based in Phoenix, AZ. The company's portfolio of next-generation platform devices is expected to be market leaders in oncology, regenerative medicine, and cardiovascular disease. Transmed7's business plan and structure enable these new transformational technologies to move from rapid development through commercial manufacturing and market deployment. The company's transformational forward-coring, zero5 biopsy devices improve patient care with broad applications to breast, soft tissue, endoscopy, laparoscopy, robotics, vascular, bone marrow, and more. The company was founded in 2010 by Eugene H. Vetter, James W. Vetter. Eugene H. Vetter has been the CEO since 2010.

Transmed7 LLC is a medical and technology-based organization that focuses on developing innovative, minimally-invasive medical devices for doctors and their patients. The private company is based in Phoenix, AZ. The company's portfolio of next-generation platform devices is expected to be market leaders in oncology, regenerative medicine, and cardiovascular disease. Transmed7's business plan and structure enable these new transformational technologies to move from rapid development through commercial manufacturing and market deployment. The company's transformational forward-coring, zero5 biopsy devices improve patient care with broad applications to breast, soft tissue, endoscopy, laparoscopy, robotics, vascular, bone marrow, and more. The company was founded in 2010 by Eugene H. Vetter, James W. Vetter. Eugene H. Vetter has been the CEO since 2010.